Table 1.
Study | AgeCoDe | EAS | MAP | LASA | HRS | ELSA | Austria | Belgium | Denmark | France | Germany | Netherlands | Sweden | Switzerland |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N | 2706 | 821 | 1428 | 2386 | 16 135 | 5383 | 3306 | 3464 | 2370 | 3385 | 3224 | 1790 | 3525 | 2116 |
Mean age (SD) | 81.73 (3.50) | 79.34 (5.40) | 80.52 (6.44) | 70.23 (7.53) | 71.42 (7.54) | 70.09 (7.28) | 70.51 (7.45) | 71.28 (7.84) | 70.75 (7.72) | 71.75 (8.15) | 69.92 (6.97) | 69.94 (7.36) | 71.05 (7.78) | 70.77 (7.64) |
Female: n; % | 1758; 65.0% | 511; 62.2% | 1010; 70.7% | 1271; 53.2% | 9442; 58.5% | 2525; 46.9% | 1900; 57.5% | 1865; 53.8% | 1262; 53.2% | 1925; 56.9% | 1586; 49.2% | 898; 50.2% | 1812; 51.4% | 1094; 51.7% |
Male: n; % | 948; 35.0% | 310; 37.8% | 418; 29.3% | 1115; 46.7% | 6693; 41.5% | 2858; 53.1% | 1406; 42.5% | 1599; 46.2% | 1108; 46.8% | 1460; 43.1% | 1638; 50.8% | 892; 49.8% | 1713; 48.6% | 1022; 48.3% |
State 1: n; % | 2081; 77.3% | 692; 84.3% | 870; 61% | 1717; 72.0% | 14525; 90.0% | 4844; 90.0% | 3084; 93.3% | 3196; 92.3% | 2166; 91.4% | 3145; 92.9% | 2996; 92.9% | 1655; 92.5% | 3284; 92.3% | 1964; 92.8% |
State 2: n; % | 544; 20.2% | 126; 15.4% | 458; 32.1% | 574; 24.0% | 1305; 8.1% | 326; 6.1% | 130; 3.9% | 184; 5.3% | 119; 5.0% | 146; 4.3% | 140; 4.3% | 86; 4.8% | 160; 4.5% | 87; 4.1% |
State 3: n; % | 67; 2.5% | 3; 0.4% | 100; 7.0% | 116; 4.9% | 309; 1.9% | 139; 2.6% | 92; 2.8% | 84; 2.4% | 85; 3.6% | 94; 2.8% | 88; 2.7% | 49; 2.7% | 111; 3.1% | 65; 3.1% |
Deaths overall | 1730 (63.9%) | 138 (16.8%) | 1050 (73.5%) | 1754 (73.5%) | 5931 (36.8%) | 1202 (22.3%) | 374 (11.31%) | 502 (14.5%) | 473 (20.0%) | 444 (13.1%) | 242 (7.5%) | 223 (12.5%) | 603 (17.1%) | 200 (9.5%) |
Note: AgeCoDe = German Study on Ageing, Cognition, and Dementia; EAS = Einstein Aging Study; ELSA = English Longitudinal Study of Aging; HRS = Health and Retirement Study; LASA = Longitudinal Aging Study Amsterdam; MAP = Memory and Aging Project. Age = mean age at baseline; State 1 = nonimpaired cognitive functioning at baseline; State 2 = mildly impaired cognitive functioning at baseline; State 3 = severely impaired cognitive functioning at baseline. Country names are all part of SHARE (Survey of Health, Ageing and Retirement in Europe).